The New York State Psychiatric Institute, located at the Columbia University Irving Medical Center in the Washington Heights neighborhood of Manhattan, New York City, was established in 1895 as one of ...

During the past decade, New York State Psychiatric Institute conducted 148 clinical trials. In the 10-year time frame, 148 clinical trials started and 137 clinical trials were completed, i.e. on average, 92.6% percent of trials that started reached the finish line to date. In the past 5 years, 72 clinical trials started and 62 clinical trials were completed. i.e. 86.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New York State Psychiatric Institute" #1 sponsor was "New York State Psychiatric Institute" with 244 trials, followed by "Research Foundation for Mental Hygiene, Inc." with 15 trials sponsored, "National Institute on Drug Abuse (NIDA)" with 10 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored and "Columbia University" with 4 trials sponsored. Other sponsors include 35 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New York State Psychiatric Institute" #1 collaborator was "National Institute of Mental Health (NIMH)" with 73 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 48 trials as a collaborator, "Columbia University" with 26 trials as a collaborator, "New York State Psychiatric Institute" with 13 trials as a collaborator and "Research Foundation for Mental Hygiene, Inc." with 10 trials as a collaborator. Other collaborators include 109 different institutions and companies that were collaborators in the rest 90 trials.

According to Clinical.Site data, the most researched conditions in "New York State Psychiatric Institute" are "Major Depressive Disorder" (29 trials), "Depression" (25 trials), "Schizophrenia" (24 trials), "Obsessive-Compulsive Disorder" (15 trials) and "Anorexia Nervosa" (13 trials). Many other conditions were trialed in "New York State Psychiatric Institute" in a lesser frequency.

Most popular intervention types in "New York State Psychiatric Institute" are "Drug" (202 trials), "Behavioral" (95 trials), "Other" (26 trials), "Device" (22 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (62 trials), "Ketamine" (9 trials), "Cannabis" (7 trials), "Naltrexone" (7 trials) and "Fluoxetine" (6 trials). Other intervention names were less common.

The vast majority of trials in "New York State Psychiatric Institute" are 298 trials for "All" genders, 15 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are 52 active trials in "New York State Psychiatric Institute". 3 are not yet recruiting, 39 are recruiting, 8 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 209 completed trials in New York State Psychiatric Institute, 4 suspended trials, and 36 terminated clinical trials to date.

Out of the total trials that were conducted in New York State Psychiatric Institute, 42 "Phase 1" clinical trials were conducted, 106 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 61 trials, and there were also 88 trials that are defined as “Not Applicable".